SCHEMBL30557631

SCHEMBL30557631

Cc1sc(C)c(C(N)=O)c1CO

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.42
ALDH1A1 P00352 10/20 0.40
KDM4E B2RXH2 5/20 0.40
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
MAPT P10636 7/20 0.38
HPGD P15428 6/20 0.38
RAB9A P51151 4/20 0.38
NPC1 O15118 3/20 0.38
GAA P10253 1/20 0.38
AIP O00170 1/20 0.38
SGTA O43765 1/20 0.38
TOMM70 O94826 1/20 0.38
STIP1 P31948 1/20 0.38
PPP5C P53041 1/20 0.38
FKBP4 Q02790 1/20 0.38
PPID Q08752 1/20 0.38
FKBP5 Q13451 1/20 0.38
FKBP8 Q14318 1/20 0.38
TOMM34 Q15785 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14364074 0.73 KMT2A (0.53) CYP1A2ALDH1A1KDM4EKMT2AMEN1
SCHEMBL3452499 0.68 CYP1A2 (0.55) CYP1A2ALDH1A1KDM4EKMT2AMEN1
SCHEMBL10679034 0.68 CYP1A2 (0.34) CYP1A2ALDH1A1KDM4EHPGDFHIT
SCHEMBL11344084 0.67 IDO1 (0.33)
SCHEMBL26784147 0.64 ALDH1A1 (0.44) CYP1A2ALDH1A1KDM4EKMT2AMEN1
SCHEMBL12111485 0.62 ALDH1A1 (0.58) CYP1A2ALDH1A1KDM4EKMT2AMEN1
SCHEMBL5080674 0.61 DAO (0.42) CYP1A2ALDH1A1KDM4EKMT2AMEN1
SCHEMBL27888882 0.61 ALDH1A1 (0.38) ALDH1A1KMT2AMEN1MAPTHPGD
SCHEMBL3451713 0.61 ALDH1A1 (0.56) CYP1A2ALDH1A1KDM4EKMT2AMEN1
SCHEMBL24525703 0.60 ADRA2A (0.43) ALDH1A1KMT2AMEN1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023158221-A1 PHARMACEUTICAL COMPOSITION FOR TREATING CANCER, COMPRISING ANTICANCER AGENT AND NOVEL COMPOUND HAVING INHIBITORY ACTIVITY WITH RESPECT TO PROSTAGLANDIN E2 RECEPTORS 주식회사 카나프테라퓨틱스 2023-08-24 WO disclosed